Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
Thrombotic event is one of the most serious complications of coronary artery disease, which
often result in myocardial infarction and even death. Even according to the standard
guidelines for antiplatelet therapy, there are still 6% to 15% of patients occur thrombotic
events, in high-risk patients, the proportion is higher, this phenomenon is called
anti-platelet drug resistance in clinical practice
The aim of this multicenter prospective, randomized, controlled study is to observed
policosanol on aspirin or clopidogrel resistance in patients with platelet aggregation after
Percutaneous Coronary Stent Implantation (PCI) and occurrence of platelet aggregation and
short-term prognosis to find new ways to the prevention of platelet aggregation .